ALDX - アルデイラ・セラピュ―ティクス (Aldeyra Therapeutics Inc.) アルデイラ・セラピュ―ティクス

 ALDXのチャート


 ALDXの企業情報

symbol ALDx
会社名 Aldeyra Therapeutics Inc (アルデイラ・セラピュ―ティクス)
分野(sector) Health Care   ヘルスケア
産業(industry) Major Pharmaceuticals  
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 アルディラ・セラピューティックス(Aldeyra Therapeutics Inc)はバイオテクノロジー企業である。同社は主に、遊離アルデヒドとして知られている天然に存在する毒性の化学種に関連すると考えられている免疫介在性、炎症性、希少疾病及び他の疾患を治療する製品の開発に集中する。NS2は、シェーグレン・ラーション症候群(SLS)、円板状エリテマトーデス、急性前部ぶどう膜炎及びマイボーム腺機能不全を伴う紅斑性酒さを含む疾患の治療のために、遊離アルデヒドの捕集・処分を可能にされている製品候補である。同社はまた、NS2と異なるアルデヒドトラップを開発している。平成26年4月7日現在、同社は48人のボランティアでの第I相臨床試験におけるNS2を評価した。   アルデイラ・セラピュ―ティクスは、米国のバイオテクノロジ―企業。アルデヒド類など有毒な化学種の発生によるものと考えられる免疫介在疾患、炎症性疾患、奇病およびその他の疾患向けに、新製品の開発を行う。アルデヒドを除去できる製品を開発し、シェ―グレン・ラ―ション症候群の治療薬NS2の製品候補としてのテストを行う。   Aldeyra Therapeutics is a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives of patients with immune-mediated diseases. Two of the company's lead investigational compounds, reproxalap and ADX-629, target RASP (reactive aldehyde species), which are elevated in ocular and systemic inflammatory disease and result in cytokine release via activation of a broad array of inflammatory factors, including NF-κB, inflammasomes, and Scavenger Receptor A. Reproxalap is being evaluated in Phase 3 clinical trials in patients with dry eye disease and allergic conjunctivitis. The company's clinical pipeline also includes ADX-2191, a dihydrofolate reductase inhibitor in Phase 3 testing for proliferative vitreoretinopathy, and ADX-1612, a chaperome inhibitor in development for COVID-19 and ovarian cancer.
本社所在地 131 Hartwell Avenue Suite 320 Lexington MA 02421 USA
代表者氏名 Todd C. Brady トッドC.ブラディ
代表者役職名 President Chief Executive Officer Director 社長兼最高経営責任者(CEO)
電話番号 +1 781-761-4904
設立年月日 38200
市場名 NASDAQ Small Cap
ipoyear 2014年
従業員数
url www.aldeyra.com
nasdaq_url https://www.nasdaq.com/symbol/aldx
adr_tso
EBITDA EBITDA(百万ドル) -29.67208
終値(lastsale) 12.8
時価総額(marketcap) 268478976
時価総額 時価総額(百万ドル) 332.67550
売上高 売上高(百万ドル) 0.00000
企業価値(EV) 企業価値(EV)(百万ドル) 292.34136
当期純利益 当期純利益(百万ドル) -29.38821
決算概要 決算概要 BRIEF: For the six months ended 30 June 2018 Aldeyra Therapeutics Inc revenues was not reported. Net loss increased 68% to $17.4M. Higher net loss reflects Interest Exp-Net of Capitalized Interest increase of 2% to $54K (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$0.72 to -$0.89.

 ALDXのテクニカル分析


 ALDXのニュース

   Lumpy Stock: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Isoray, Inc. (AMEX:ISR)  2021/07/05 02:52:38 Stock Equity
Aldeyra Therapeutics, Inc. (ALDX) with the stream of -3.45% also noticed, India Isoray, Inc. (ISR) encountered a rapid change of -1.64% in the last hour of Fridays trading session. Aldeyra The post Lumpy Stock: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .
   Aldeyra Therapeutics added to Russell 3000 Index, Russell 2000 Index  2021/07/01 12:13:52 Seeking Alpha
   Stock on fire: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), VEREIT, Inc. (NYSE:VER)  2021/06/15 22:38:32 Stock Equity
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) with the stream of -1.55% also noticed, India VEREIT, Inc. (NYSE:VER) encountered a rapid change of -1.00% in the last hour of Tuesdays trading session. Aldeyra The post Stock on fire: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), VEREIT, Inc. (NYSE:VER) appeared first on Stocks Equity .
   Aldeyra Therapeutics: A New Approach To Ocular Inflammatory Diseases With Impressive Clinical Data  2021/06/01 21:55:30 Seeking Alpha
   Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference  2021/05/27 00:00:00 BioSpace
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 4:30 p.m. ET.
   Lumpy Stock: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Isoray, Inc. (AMEX:ISR)  2021/07/05 02:52:38 Stock Equity
Aldeyra Therapeutics, Inc. (ALDX) with the stream of -3.45% also noticed, India Isoray, Inc. (ISR) encountered a rapid change of -1.64% in the last hour of Fridays trading session. Aldeyra The post Lumpy Stock: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), Isoray, Inc. (AMEX:ISR) appeared first on Stocks Equity .
   Aldeyra Therapeutics added to Russell 3000 Index, Russell 2000 Index  2021/07/01 12:13:52 Seeking Alpha
   Stock on fire: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), VEREIT, Inc. (NYSE:VER)  2021/06/15 22:38:32 Stock Equity
Aldeyra Therapeutics, Inc. (NASDAQ:ALDX) with the stream of -1.55% also noticed, India VEREIT, Inc. (NYSE:VER) encountered a rapid change of -1.00% in the last hour of Tuesdays trading session. Aldeyra The post Stock on fire: Aldeyra Therapeutics, Inc. (NASDAQ:ALDX), VEREIT, Inc. (NYSE:VER) appeared first on Stocks Equity .
   Aldeyra Therapeutics: A New Approach To Ocular Inflammatory Diseases With Impressive Clinical Data  2021/06/01 21:55:30 Seeking Alpha
   Aldeyra Therapeutics to Participate in Fireside Chat at the Jefferies Virtual Healthcare Conference  2021/05/27 00:00:00 BioSpace
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a fireside chat at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021, at 4:30 p.m. ET.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 アルデイラ・セラピュ―ティクス ALDX Aldeyra Therapeutics Inc.)

 twitter  (公式ツイッターやCEOツイッターなど)